| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 3.95e-05 | 28 | 280 | 5 | GO:0005251 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CLCN5 KCNB1 KCNC3 KCNC4 KCNG1 ABCC8 CACNA1C CACNA2D4 CACNG6 KCNT2 KCNG4 | 5.45e-05 | 182 | 280 | 11 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | KCNB1 KCNC3 KCNC4 KCNG1 ABCC8 CACNA1C CACNA2D4 CACNG6 KCNT2 KCNG4 | 5.84e-05 | 152 | 280 | 10 | GO:0022843 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CLCN5 KCNB1 KCNC3 KCNC4 KCNG1 ABCC8 CACNA1C CACNA2D4 CACNG6 KCNT2 KCNG4 | 6.02e-05 | 184 | 280 | 11 | GO:0022832 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.07e-05 | 49 | 280 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | transporter activity | SLC17A2 SLC16A13 ABCB7 ABCA7 CHRNA4 CLCN5 KCNB1 KCNC3 KCNC4 KCNG1 ABCC8 PKD1 PEX2 SLC38A11 RFT1 MFSD1 SLC39A5 SLC29A4 ABCC10 VMP1 LRRC8C CACNA1C ABCC1 GRAMD1A GJC1 APOA1 AQP3 SLC1A1 SLC6A12 ABCG1 CACNA2D4 CACNG6 SLC7A3 KCNT2 KCNG4 ATP12A | 6.15e-05 | 1289 | 280 | 36 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC17A2 SLC16A13 ABCB7 ABCA7 CHRNA4 CLCN5 KCNB1 KCNC3 KCNC4 KCNG1 ABCC8 PKD1 PEX2 SLC38A11 MFSD1 SLC39A5 SLC29A4 ABCC10 LRRC8C CACNA1C ABCC1 GJC1 AQP3 SLC1A1 SLC6A12 ABCG1 CACNA2D4 CACNG6 SLC7A3 KCNT2 KCNG4 ATP12A | 2.74e-04 | 1180 | 280 | 32 | GO:0022857 |
| GeneOntologyBiologicalProcess | negative regulation of production of molecular mediator of immune response | 1.14e-05 | 56 | 284 | 7 | GO:0002701 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT2 HMCN2 PTPRF PKD1 SDK1 FAT4 SDK2 PCDHAC1 CDH24 CELSR1 CELSR3 CDH3 | 1.16e-05 | 187 | 284 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | associative learning | RELN TSC1 ABCA7 RAPGEF3 ABCC8 DDHD2 CACNA1C DEAF1 SLC1A1 TANC1 | 1.30e-05 | 130 | 284 | 10 | GO:0008306 |
| GeneOntologyBiologicalProcess | phospholipid efflux | 4.26e-05 | 15 | 284 | 4 | GO:0033700 | |
| GeneOntologyCellularComponent | low-density lipoprotein particle | 5.41e-05 | 16 | 285 | 4 | GO:0034362 | |
| GeneOntologyCellularComponent | basal part of cell | EPPK1 DAG1 PHLDB1 RAPGEF3 PKD1 SLC39A5 SLC29A4 ABCC10 ABCC1 FLOT2 CR1 AQP3 SLC6A12 LLGL1 ATP12A TACSTD2 | 6.83e-05 | 378 | 285 | 16 | GO:0045178 |
| GeneOntologyCellularComponent | basal plasma membrane | EPPK1 DAG1 RAPGEF3 PKD1 SLC39A5 SLC29A4 ABCC10 ABCC1 FLOT2 CR1 AQP3 SLC6A12 LLGL1 ATP12A TACSTD2 | 1.14e-04 | 354 | 285 | 15 | GO:0009925 |
| GeneOntologyCellularComponent | adherens junction | MYH9 PDLIM7 DAG1 FAT2 ALOX15B TBCD FLOT2 LAMA3 CDH24 LLGL1 CDH3 | 1.66e-04 | 212 | 285 | 11 | GO:0005912 |
| GeneOntologyCellularComponent | protein-lipid complex | 4.37e-04 | 47 | 285 | 5 | GO:0032994 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | EPPK1 DAG1 PKD1 SLC39A5 SLC29A4 ABCC10 ABCC1 FLOT2 CR1 AQP3 SLC6A12 LLGL1 ATP12A | 4.81e-04 | 320 | 285 | 13 | GO:0016323 |
| Domain | - | NBEAL1 ADGRV1 FAT2 ADGRD1 FAT4 LAMA3 NBEA CELSR1 CELSR3 CSPG4 LRBA | 1.68e-07 | 95 | 278 | 11 | 2.60.120.200 |
| Domain | Ig_I-set | SIGLEC8 LINGO3 ISLR FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL SDK1 SIGLEC12 SDK2 MXRA5 SIGLEC11 SIGLEC1 | 1.72e-07 | 190 | 278 | 15 | IPR013098 |
| Domain | I-set | SIGLEC8 LINGO3 ISLR FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL SDK1 SIGLEC12 SDK2 MXRA5 SIGLEC11 SIGLEC1 | 1.72e-07 | 190 | 278 | 15 | PF07679 |
| Domain | DUF4704 | 2.37e-07 | 5 | 278 | 4 | IPR031570 | |
| Domain | DUF4704 | 2.37e-07 | 5 | 278 | 4 | PF15787 | |
| Domain | IGc2 | SIGLEC8 LINGO3 ISLR FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL VSIG10L SDK1 SIGLEC12 SDK2 MXRA5 SIGLEC11 SIGLEC1 | 5.01e-07 | 235 | 278 | 16 | SM00408 |
| Domain | Ig_sub2 | SIGLEC8 LINGO3 ISLR FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL VSIG10L SDK1 SIGLEC12 SDK2 MXRA5 SIGLEC11 SIGLEC1 | 5.01e-07 | 235 | 278 | 16 | IPR003598 |
| Domain | WD40_repeat_dom | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 PAN2 WDR90 NBEA TEP1 WDR19 SF3B3 LLGL1 TLE3 WDR45B LRBA | 5.39e-07 | 297 | 278 | 18 | IPR017986 |
| Domain | PH_BEACH | 7.04e-07 | 6 | 278 | 4 | PF14844 | |
| Domain | WD40 | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 WDR90 NBEA TEP1 WDR19 LLGL1 TLE3 WDR45B LRBA | 1.82e-06 | 259 | 278 | 16 | PF00400 |
| Domain | WD40 | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 WDR90 NBEA TEP1 WDR19 LLGL1 TLE3 WDR45B LRBA | 2.83e-06 | 268 | 278 | 16 | SM00320 |
| Domain | WD40/YVTN_repeat-like_dom | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 PAN2 WDR90 NBEA TEP1 WDR19 SF3B3 LLGL1 TLE3 WDR45B LRBA | 3.02e-06 | 335 | 278 | 18 | IPR015943 |
| Domain | PH_BEACH | 3.21e-06 | 8 | 278 | 4 | PS51783 | |
| Domain | PH-BEACH_dom | 3.21e-06 | 8 | 278 | 4 | IPR023362 | |
| Domain | - | 3.21e-06 | 8 | 278 | 4 | 2.30.29.40 | |
| Domain | WD40_repeat | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 WDR90 NBEA TEP1 WDR19 LLGL1 TLE3 WDR45B LRBA | 3.42e-06 | 272 | 278 | 16 | IPR001680 |
| Domain | WD_REPEATS_1 | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 WDR90 NBEA TEP1 WDR19 LLGL1 TLE3 WDR45B LRBA | 4.52e-06 | 278 | 278 | 16 | PS00678 |
| Domain | WD_REPEATS_2 | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 WDR90 NBEA TEP1 WDR19 LLGL1 TLE3 WDR45B LRBA | 4.74e-06 | 279 | 278 | 16 | PS50082 |
| Domain | WD_REPEATS_REGION | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 WDR90 NBEA TEP1 WDR19 LLGL1 TLE3 WDR45B LRBA | 4.74e-06 | 279 | 278 | 16 | PS50294 |
| Domain | ConA-like_dom | NBEAL1 ADGRV1 CMYA5 FAT2 NBEAL2 ADGRD1 FAT4 LAMA3 NBEA CELSR1 MALRD1 CELSR3 CSPG4 LRBA | 5.45e-06 | 219 | 278 | 14 | IPR013320 |
| Domain | BEACH | 5.71e-06 | 9 | 278 | 4 | PS50197 | |
| Domain | Beach | 5.71e-06 | 9 | 278 | 4 | SM01026 | |
| Domain | BEACH_dom | 5.71e-06 | 9 | 278 | 4 | IPR000409 | |
| Domain | Beach | 5.71e-06 | 9 | 278 | 4 | PF02138 | |
| Domain | - | 5.71e-06 | 9 | 278 | 4 | 1.10.1540.10 | |
| Domain | EGF-like_CS | RELN ADAM18 LAMC3 FAT2 HMCN2 FAT4 LAMA3 ADAM29 THBD CELSR1 MALRD1 CELSR3 MEGF8 FBN3 EPHA10 | 9.17e-06 | 261 | 278 | 15 | IPR013032 |
| Domain | EGF_2 | RELN ADAM18 LAMC3 FAT2 HMCN2 FAT4 LAMA3 ADAM29 THBD CELSR1 MALRD1 CELSR3 MEGF8 FBN3 EPHA10 | 1.10e-05 | 265 | 278 | 15 | PS01186 |
| Domain | - | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 PAN2 WDR90 NBEA TEP1 WDR19 LLGL1 TLE3 WDR45B LRBA | 1.12e-05 | 333 | 278 | 17 | 2.130.10.10 |
| Domain | GPS | 1.16e-05 | 35 | 278 | 6 | PF01825 | |
| Domain | GPS | 1.38e-05 | 36 | 278 | 6 | PS50221 | |
| Domain | GPS | 1.63e-05 | 37 | 278 | 6 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 1.91e-05 | 38 | 278 | 6 | PS50025 | |
| Domain | EGF-like_dom | RELN ADAM18 LAMC3 FAT2 HMCN2 FAT4 LAMA3 ADAM29 THBD CELSR1 MALRD1 CELSR3 MEGF8 FBN3 | 2.33e-05 | 249 | 278 | 14 | IPR000742 |
| Domain | Laminin_G_2 | 2.59e-05 | 40 | 278 | 6 | PF02210 | |
| Domain | EGF_1 | RELN ADAM18 LAMC3 FAT2 HMCN2 FAT4 LAMA3 ADAM29 THBD CELSR1 MALRD1 CELSR3 MEGF8 FBN3 | 3.03e-05 | 255 | 278 | 14 | PS00022 |
| Domain | ABC_transporter_CS | 3.45e-05 | 42 | 278 | 6 | IPR017871 | |
| Domain | K_chnl_volt-dep_Kv | 4.35e-05 | 27 | 278 | 5 | IPR003968 | |
| Domain | LamG | 4.52e-05 | 44 | 278 | 6 | SM00282 | |
| Domain | Adcy_conserved_dom | 6.31e-05 | 6 | 278 | 3 | IPR009398 | |
| Domain | DUF1053 | 6.31e-05 | 6 | 278 | 3 | PF06327 | |
| Domain | EGF_LAM_2 | 7.40e-05 | 30 | 278 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 7.40e-05 | 30 | 278 | 5 | PS01248 | |
| Domain | ABC_TRANSPORTER_2 | 7.48e-05 | 48 | 278 | 6 | PS50893 | |
| Domain | ABC_tran | 7.48e-05 | 48 | 278 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 8.42e-05 | 49 | 278 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 9.45e-05 | 50 | 278 | 6 | IPR003439 | |
| Domain | VG_K_chnl | 1.19e-04 | 33 | 278 | 5 | IPR028325 | |
| Domain | T1-type_BTB | 1.32e-04 | 53 | 278 | 6 | IPR003131 | |
| Domain | BTB_2 | 1.32e-04 | 53 | 278 | 6 | PF02214 | |
| Domain | GPS | 1.38e-04 | 34 | 278 | 5 | SM00303 | |
| Domain | EGF_Lam | 1.59e-04 | 35 | 278 | 5 | SM00180 | |
| Domain | Laminin_EGF | 1.59e-04 | 35 | 278 | 5 | PF00053 | |
| Domain | AC_N | 1.73e-04 | 8 | 278 | 3 | IPR032628 | |
| Domain | AC_N | 1.73e-04 | 8 | 278 | 3 | PF16214 | |
| Domain | Adcy | 1.73e-04 | 8 | 278 | 3 | IPR030672 | |
| Domain | - | 1.98e-04 | 57 | 278 | 6 | 1.20.120.350 | |
| Domain | Channel_four-helix_dom | 1.98e-04 | 57 | 278 | 6 | IPR027359 | |
| Domain | IG | SIGLEC8 LINGO3 FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL VSIG10L SDK1 SIGLEC12 SDK2 MXRA5 VSTM2A NFAM1 SIGLEC11 SIGLEC1 | 2.04e-04 | 421 | 278 | 17 | SM00409 |
| Domain | Ig_sub | SIGLEC8 LINGO3 FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL VSIG10L SDK1 SIGLEC12 SDK2 MXRA5 VSTM2A NFAM1 SIGLEC11 SIGLEC1 | 2.04e-04 | 421 | 278 | 17 | IPR003599 |
| Domain | Laminin_G | 2.18e-04 | 58 | 278 | 6 | IPR001791 | |
| Domain | EGF | RELN LAMC3 GPR179 FAT2 FAT4 LAMA3 THBD CELSR1 MALRD1 CELSR3 MEGF8 FBN3 | 2.20e-04 | 235 | 278 | 12 | SM00181 |
| Domain | EGF_3 | RELN ADAM18 FAT2 HMCN2 FAT4 ADAM29 THBD CELSR1 MALRD1 CELSR3 MEGF8 FBN3 | 2.20e-04 | 235 | 278 | 12 | PS50026 |
| Domain | DUF676 | 2.21e-04 | 2 | 278 | 2 | PF05057 | |
| Domain | Potassium_chann | 2.21e-04 | 2 | 278 | 2 | PF11404 | |
| Domain | DUF1088 | 2.21e-04 | 2 | 278 | 2 | PF06469 | |
| Domain | DUF3657 | 2.21e-04 | 2 | 278 | 2 | IPR022122 | |
| Domain | DUF1088 | 2.21e-04 | 2 | 278 | 2 | IPR010508 | |
| Domain | DUF3657 | 2.21e-04 | 2 | 278 | 2 | PF12394 | |
| Domain | K_chnl_volt-dep_Kv3_ID | 2.21e-04 | 2 | 278 | 2 | IPR021105 | |
| Domain | PQQ_2 | 2.21e-04 | 2 | 278 | 2 | PF13360 | |
| Domain | DUF676_lipase-like | 2.21e-04 | 2 | 278 | 2 | IPR007751 | |
| Domain | Laminin_EGF | 2.37e-04 | 38 | 278 | 5 | IPR002049 | |
| Domain | GPCR_2_extracellular_dom | 3.03e-04 | 40 | 278 | 5 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 3.03e-04 | 40 | 278 | 5 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 3.03e-04 | 40 | 278 | 5 | PS50227 | |
| Domain | Cadherin-like | 3.46e-04 | 116 | 278 | 8 | IPR015919 | |
| Domain | Cys-rich_flank_reg_C | 3.91e-04 | 90 | 278 | 7 | IPR000483 | |
| Domain | LRRCT | 3.91e-04 | 90 | 278 | 7 | SM00082 | |
| Domain | ABC_membrane | 4.04e-04 | 24 | 278 | 4 | PF00664 | |
| Domain | IG_LIKE | SIGLEC8 LINGO3 ISLR FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL VSIG10L SDK1 SIGLEC12 SDK2 MXRA5 VSTM2A NFAM1 SIGLEC11 SIGLEC1 | 4.29e-04 | 491 | 278 | 18 | PS50835 |
| Domain | EGF_CA | 4.85e-04 | 122 | 278 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.41e-04 | 124 | 278 | 8 | IPR001881 | |
| Domain | Growth_fac_rcpt_ | 5.59e-04 | 156 | 278 | 9 | IPR009030 | |
| Domain | Ig-like_dom | SIGLEC8 LINGO3 ISLR FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL VSIG10L SDK1 SIGLEC12 SDK2 MXRA5 VSTM2A NFAM1 SIGLEC11 SIGLEC1 | 5.70e-04 | 503 | 278 | 18 | IPR007110 |
| Domain | ARM-type_fold | NBEAL1 IFT172 EFR3A NOP9 NBEAL2 ANKAR CLTC TBCD DNAJC13 NBEA HEATR5A RIF1 THADA LRBA | 5.90e-04 | 339 | 278 | 14 | IPR016024 |
| Domain | LRRNT | 6.55e-04 | 98 | 278 | 7 | SM00013 | |
| Domain | LRRNT | 6.55e-04 | 98 | 278 | 7 | IPR000372 | |
| Domain | K_chnl_volt-dep_Kv6 | 6.56e-04 | 3 | 278 | 2 | IPR003969 | |
| Domain | ASX_HYDROXYL | 7.39e-04 | 100 | 278 | 7 | PS00010 | |
| Domain | ABC_TM1F | 7.42e-04 | 28 | 278 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 7.42e-04 | 28 | 278 | 4 | IPR011527 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 8.64e-04 | 50 | 278 | 5 | PS00650 | |
| Domain | 7tm_2 | 8.64e-04 | 50 | 278 | 5 | PF00002 | |
| Domain | Ig-like_fold | SIGLEC8 DAG1 LINGO3 ISLR CMYA5 FCRL1 PXDN HMCN2 PTPRD PTPRF PXDNL VSIG10L SDK1 SIGLEC12 SDK2 MXRA5 VSTM2A VWA1 NFAM1 SIGLEC11 SIGLEC1 EPHA10 | 9.25e-04 | 706 | 278 | 22 | IPR013783 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.04e-03 | 106 | 278 | 7 | IPR000152 | |
| Domain | Cadherin_CS | 1.23e-03 | 109 | 278 | 7 | IPR020894 | |
| Domain | K_chnl_volt-dep_Kv3 | 1.30e-03 | 4 | 278 | 2 | IPR003974 | |
| Domain | AAA+_ATPase | 1.43e-03 | 144 | 278 | 8 | IPR003593 | |
| Domain | AAA | 1.43e-03 | 144 | 278 | 8 | SM00382 | |
| Domain | CADHERIN_1 | 1.52e-03 | 113 | 278 | 7 | PS00232 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | ADCY6 ADCY7 FASN KCNB1 RAPGEF3 ABCC8 GNAS CACNA1C ADCY4 MLXIPL | 4.34e-06 | 108 | 208 | 10 | M17034 |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 7.01e-06 | 90 | 208 | 9 | M835 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 8.63e-06 | 20 | 208 | 5 | M759 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ADCY6 ADCY7 CHRNA4 PTPRD PTPRF KCNB1 KCNC3 KCNC4 KCNG1 ABCC8 FLOT2 ADCY4 GJC1 SLC1A1 SLC6A12 KCNG4 | 3.79e-05 | 335 | 208 | 16 | MM14503 |
| Pathway | REACTOME_NEURONAL_SYSTEM | ADCY6 ADCY7 CHRNA4 PTPRD PTPRF KCNB1 KCNC3 KCNC4 KCNG1 ABCC8 FLOT2 ADCY4 GJC1 NBEA SLC1A1 SLC6A12 KCNG4 PRKX | 3.88e-05 | 411 | 208 | 18 | M735 |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.25e-05 | 44 | 208 | 6 | M11911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 5.53e-05 | 15 | 208 | 4 | M47794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 5.53e-05 | 15 | 208 | 4 | M47504 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.93e-05 | 29 | 208 | 5 | M47515 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 7.29e-05 | 16 | 208 | 4 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 7.29e-05 | 16 | 208 | 4 | M47650 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 8.29e-05 | 31 | 208 | 5 | M47507 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 9.43e-05 | 17 | 208 | 4 | M26995 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 9.43e-05 | 17 | 208 | 4 | MM14552 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 9.70e-05 | 32 | 208 | 5 | M47506 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 1.11e-04 | 52 | 208 | 6 | M5785 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.20e-04 | 18 | 208 | 4 | M524 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.98e-04 | 37 | 208 | 5 | M749 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.71e-04 | 61 | 208 | 6 | MM15071 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.24e-04 | 41 | 208 | 5 | M512 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 3.24e-04 | 41 | 208 | 5 | MM14546 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 3.52e-04 | 10 | 208 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 3.52e-04 | 10 | 208 | 3 | MM14668 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.88e-04 | 24 | 208 | 4 | M47520 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 4.07e-04 | 43 | 208 | 5 | M933 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 4.07e-04 | 43 | 208 | 5 | M29837 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 4.07e-04 | 43 | 208 | 5 | M1056 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCB7 APOBR ABCA7 ADCY6 ADCY7 CLCN5 CLTC GNAS SLC39A5 SLC29A4 ABCC10 LRRC8C ABCC1 ADCY4 PEX3 APOA1 AQP3 SLC1A1 SLC6A12 ABCG1 SLC7A3 CES3 ATP12A | 5.49e-04 | 736 | 208 | 23 | M27287 |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 6.19e-04 | 27 | 208 | 4 | M47518 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 6.51e-04 | 99 | 208 | 7 | MM14986 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 6.67e-04 | 72 | 208 | 6 | MM14631 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 7.14e-04 | 28 | 208 | 4 | M47647 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 7.33e-04 | 101 | 208 | 7 | M1979 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 8.19e-04 | 29 | 208 | 4 | M47627 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 8.24e-04 | 103 | 208 | 7 | M758 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 9.86e-04 | 52 | 208 | 5 | M920 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.02e-03 | 78 | 208 | 6 | M1921 | |
| Pathway | WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS | 1.02e-03 | 14 | 208 | 3 | M45553 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.02e-03 | 14 | 208 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.02e-03 | 14 | 208 | 3 | M750 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.17e-03 | 54 | 208 | 5 | M26911 | |
| Pathway | PID_LPA4_PATHWAY | 1.26e-03 | 15 | 208 | 3 | M56 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 TRNP1 SPHK2 EPPK1 SREBF1 IPP EML2 LAMC3 NCLN ABCA7 ADCY7 JAK3 FASN PHLDB1 PTPRF KCNG1 NBEAL2 MCM3AP PKD1 WDR90 PREX1 MED12 ABCC10 TBCD NLRX1 TEP1 DHX30 CCDC142 TRAF4 CELSR1 THADA C2CD3 CELSR3 MEGF8 NISCH CSPG4 HPS6 ANKRD34A ZFYVE26 TANC1 LRBA SYVN1 | 1.71e-16 | 1105 | 287 | 42 | 35748872 |
| Pubmed | MYH9 CYP51A1 NCLN PFKP APOBR B3GAT3 PARP4 FASN CLCN5 NBEAL2 NUP210 CLTC PEX2 GNAS MED12 LRRC8C ABCC1 FLOT2 MED6 DNAJC13 PEX3 KLC2 TMBIM6 APH1A NISCH HPS6 NUP93 LRBA SYVN1 MAN1B1 ACSL5 EXOC4 | 3.50e-09 | 1168 | 287 | 32 | 19946888 | |
| Pubmed | RAPGEF5 IFT172 TSC1 ADCY6 DCAF5 PHLDB1 PXDN KLHL13 MCM3AP CLTC NAV3 BAIAP3 HEATR5A DHX30 MEGF8 TLE3 NISCH SYVN1 | 1.05e-08 | 407 | 287 | 18 | 12693553 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MYH9 ABCB7 EMC1 CYP51A1 SREBF1 DAG1 LAMC3 NCLN MBOAT2 ABCA7 B3GAT3 PXDN PTPRF PGAP1 NUP210 RFT1 VMP1 LRRC8C ABCC1 FAT4 MAN2B2 SPTLC2 GRAMD1A SERPINH1 TXNDC12 CELSR1 THADA CELSR3 MEGF8 CSPG4 MAN1B1 | 2.45e-08 | 1201 | 287 | 31 | 35696571 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EMC1 CYP51A1 DAG1 NCLN PFKP B3GAT3 FASN PXDN PTPRF NUP210 CLTC RFT1 TARS1 TBCD ABCC1 SPTLC2 ACAD9 GRAMD1A SERPINH1 ANKRD13A THADA APH1A NISCH SEC23IP NUP93 MAN1B1 EXOC4 | 2.53e-08 | 942 | 287 | 27 | 31073040 |
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 2.69e-08 | 23 | 287 | 6 | 10708515 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ADGRV1 CEP170 TMCO4 PHLDB1 KLHL9 PXDN TLE5 PTPRN2 ABCC8 ANKAR NUP210 GNAS POLK BAIAP3 DAGLA ADGRD1 TBCD CACNA1C DNAJC13 MAN2B2 LAMA3 TEP1 NXN SLC1A1 ABCG1 THADA TLE3 WDR45B TANC1 LRBA PRKX MAN1B1 EXOC4 | 2.91e-07 | 1489 | 287 | 33 | 28611215 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SELENOS ABCB7 PDLIM7 CYP51A1 SREBF1 DAG1 WDR18 NCLN FASN NOP9 PTPRF NUP210 CLTC GNAS MED12 TBCD VMP1 FLOT2 DNAJC13 GRAMD1A ZNF407 SERPINH1 TXNDC12 RIF1 CSPG4 NUP93 SYVN1 ACSL5 EXOC4 | 2.96e-07 | 1203 | 287 | 29 | 29180619 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAG1 TSC1 ADCY6 EFR3A PHLDB1 PTPRF NBEAL2 FAM135A ABCC1 FLOT2 USP43 GJC1 THBD LLGL1 CSPG4 STON2 TANC1 LRBA TACSTD2 | 3.34e-07 | 569 | 287 | 19 | 30639242 |
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 5.54e-07 | 9 | 287 | 4 | 9417641 | |
| Pubmed | Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk. | 5.56e-07 | 3 | 287 | 3 | 19252981 | |
| Pubmed | 5.56e-07 | 3 | 287 | 3 | 28027934 | ||
| Pubmed | 9.17e-07 | 10 | 287 | 4 | 16615126 | ||
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 2.13e-06 | 12 | 287 | 4 | 9611134 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ABCB7 EMC1 ECHDC1 CYP51A1 WDR18 NCLN PFKP FASN KLHL9 TPP1 KLHL13 NUP210 CLTC PYCR1 GNAS MED12 TARS1 TBCD MED6 SPTLC2 TMBIM6 SERPINH1 DHX30 PTOV1 RIF1 SF3B3 AASS NUP93 | 2.23e-06 | 1257 | 287 | 28 | 37317656 |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 3.00e-06 | 142 | 287 | 9 | 19851296 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 3.07e-06 | 182 | 287 | 10 | 31067453 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | MYH9 ABCB7 RUSC1 NIF3L1 LAMC3 TPP1 PKD1 WDR90 POLK BAIAP3 MFSD1 ABCC10 ABCC1 FLOT2 KLC2 SMTN PTOV1 RIF1 TRAF4 THADA AASS INTS13 TLE3 | 3.18e-06 | 925 | 287 | 23 | 28986522 |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 3.18e-06 | 143 | 287 | 9 | 20198315 | |
| Pubmed | 5.49e-06 | 5 | 287 | 3 | 19074135 | ||
| Pubmed | The cell adhesion molecule Sdk1 shapes assembly of a retinal circuit that detects localized edges. | 5.49e-06 | 5 | 287 | 3 | 34545809 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 6.38e-06 | 84 | 287 | 7 | 15203218 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 7.26e-06 | 33 | 287 | 5 | 25713288 | |
| Pubmed | 7.64e-06 | 16 | 287 | 4 | 17567809 | ||
| Pubmed | EMC1 PDLIM7 RCC1 TSC1 BCOR EFR3A PTPRD PTPRF PTPRN2 NUP210 CLTC PYCR1 ABCC1 DNAJC13 GRAMD1A DUSP8 NBEA PPEF1 TXNDC12 RIF1 C2CD3 TLE3 TANC1 NUP93 | 7.85e-06 | 1049 | 287 | 24 | 27880917 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SELENOS PFKP ADCY6 B3GAT3 PTPRF ALG14 MCM3AP PEX2 RFT1 ABCC10 VMP1 SPTLC2 NLRX1 TUT1 RIF1 THADA CACNG6 APH1A HPS6 SEC23IP NUP93 LRBA ATP12A MAN1B1 | 9.47e-06 | 1061 | 287 | 24 | 33845483 |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | SELENOS EMC1 CYP51A1 NCLN MBOAT2 NUP210 RFT1 VMP1 LRRC8C ABCC1 SPTLC2 ACAD9 GRAMD1A SERPINH1 SYVN1 | 9.56e-06 | 468 | 287 | 15 | 31056421 |
| Pubmed | EMC1 ADGRV1 BCOR EFR3A KLHL9 TRANK1 NBEAL2 PAN2 WDR90 DAGLA CERK SDK2 WDR19 SF3B3 CELSR3 NUP93 | 9.94e-06 | 529 | 287 | 16 | 14621295 | |
| Pubmed | ABCB7 EMC1 WDR18 RCC1 NCLN PFKP CEP170 FASN NOP9 PXDN COG6 NUP210 CLTC PYCR1 GNAS VMP1 ABCC1 FLOT2 SPTLC2 ACAD9 GRAMD1A SERPINH1 SMTN ANKRD13A THADA SF3B3 AASS NUP93 EXOC4 | 1.01e-05 | 1440 | 287 | 29 | 30833792 | |
| Pubmed | Dystroglycan is a scaffold for extracellular axon guidance decisions. | 1.09e-05 | 6 | 287 | 3 | 30758284 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PDLIM7 IFT172 ECHDC1 NCLN PFKP BBS9 ADCY6 CEP170 PAN2 RFT1 TBCD DNAJC13 ACAD9 NXN SLC1A1 DHX30 WDR19 PTOV1 ANKRD13A RIF1 DZANK1 THADA SF3B3 NISCH SEC23IP ANKRD34A EXOC4 | 1.60e-05 | 1321 | 287 | 27 | 27173435 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 EMC1 PDLIM7 WDR18 RCC1 NCLN PFKP CEP170 FASN NOP9 PHLDB1 PTPRF NUP210 CLTC GNAS TARS1 FLOT2 SERPINH1 DHX30 ARG1 RIF1 SF3B3 NUP93 | 1.63e-05 | 1024 | 287 | 23 | 24711643 |
| Pubmed | Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen. | 1.90e-05 | 7 | 287 | 3 | 28100677 | |
| Pubmed | 1.90e-05 | 7 | 287 | 3 | 19164805 | ||
| Pubmed | EMC1 PARP4 PYCR1 TBCD DNAJC13 DPYSL4 DHX30 AASS NISCH CSPG4 STON2 EXOC4 | 1.90e-05 | 325 | 287 | 12 | 36168628 | |
| Pubmed | 1.92e-05 | 40 | 287 | 5 | 16382104 | ||
| Pubmed | 2.17e-05 | 41 | 287 | 5 | 19343720 | ||
| Pubmed | NCLN BCOR PARP4 PHLDB1 PTPRN2 PYCR1 PREX1 FLOT2 FAT4 MXRA5 NBEA WDR19 MEGF8 AASS INTS13 TLE3 SEC23IP | 2.66e-05 | 638 | 287 | 17 | 31182584 | |
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 3.56e-05 | 149 | 287 | 8 | 25231870 | |
| Pubmed | 4.50e-05 | 9 | 287 | 3 | 9693030 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 4.50e-05 | 9 | 287 | 3 | 17229090 | |
| Pubmed | 4.50e-05 | 9 | 287 | 3 | 12503609 | ||
| Pubmed | MYH9 PDLIM7 ECHDC1 TSC1 NCLN PFKP CEP170 CLTC PYCR1 DNAJC13 ACAD9 SERPINH1 DHX30 SF3B3 NUP93 EXOC4 | 4.64e-05 | 601 | 287 | 16 | 33658012 | |
| Pubmed | 4.69e-05 | 114 | 287 | 7 | 21150319 | ||
| Pubmed | EMC1 WDR18 NCLN PFKP DCAF5 CEP170 PARP4 NUP210 PYCR1 TBCD DNAJC13 SPTLC2 NLRX1 RIF1 HPS6 SEC23IP | 5.11e-05 | 606 | 287 | 16 | 36538041 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 6.39e-05 | 10 | 287 | 3 | 8663304 | |
| Pubmed | Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development. | 6.39e-05 | 10 | 287 | 3 | 25908104 | |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 6.39e-05 | 10 | 287 | 3 | 11884542 | |
| Pubmed | 6.39e-05 | 10 | 287 | 3 | 25320078 | ||
| Pubmed | TRNP1 MYH9 EPPK1 SREBF1 NIF3L1 RCC1 FASN PHLDB1 PTPRF NUP210 PYCR1 VSIG10L2 ABCC1 FAT4 TRAF4 HPS6 NUP93 EXOC4 | 6.42e-05 | 754 | 287 | 18 | 35906200 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYH9 SELENOS ABCB7 EMC1 NCLN POLA2 B3GAT3 CEP170 TLE5 NUP210 RFT1 ABCC1 MAN2B2 SPTLC2 ACAD9 PEX3 AASS TLE3 | 6.42e-05 | 754 | 287 | 18 | 33060197 |
| Pubmed | Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease. | 6.79e-05 | 2 | 287 | 2 | 24158982 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 32015129 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 15169895 | ||
| Pubmed | KCNG4 Genetic Variant Linked to Migraine Prevents Expression of KCNB1. | 6.79e-05 | 2 | 287 | 2 | 39201645 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 30768374 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 12917409 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 30150416 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 17141191 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 18420801 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 30078215 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 12897158 | ||
| Pubmed | ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain. | 6.79e-05 | 2 | 287 | 2 | 27472885 | |
| Pubmed | Study of adenylyl cyclase-GαS interactions and identification of novel AC ligands. | 6.79e-05 | 2 | 287 | 2 | 29327289 | |
| Pubmed | p125 is localized in endoplasmic reticulum exit sites and involved in their organization. | 6.79e-05 | 2 | 287 | 2 | 15623529 | |
| Pubmed | A family with hypothyroidism caused by fatty acid synthase and apolipoprotein B receptor mutations. | 6.79e-05 | 2 | 287 | 2 | 30272292 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 12213084 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 16198472 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 19168031 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 37899701 | ||
| Pubmed | Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability. | 6.79e-05 | 2 | 287 | 2 | 25888683 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 16204055 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 24219083 | ||
| Pubmed | Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. | 6.79e-05 | 2 | 287 | 2 | 15496471 | |
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 6.79e-05 | 2 | 287 | 2 | 12230981 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 9228084 | ||
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 6.79e-05 | 2 | 287 | 2 | 27644106 | |
| Pubmed | Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model. | 6.79e-05 | 2 | 287 | 2 | 24994926 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 15610163 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 26505474 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 37880612 | ||
| Pubmed | Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use. | 6.79e-05 | 2 | 287 | 2 | 38167725 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 24123876 | ||
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 6.79e-05 | 2 | 287 | 2 | 15213259 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 31189668 | ||
| Pubmed | DNA methylation of lipid-related genes affects blood lipid levels. | 6.79e-05 | 2 | 287 | 2 | 25583993 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 7665159 | ||
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 6.79e-05 | 2 | 287 | 2 | 15703275 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 32248400 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 15994327 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 22786746 | ||
| Pubmed | GABA and glutamate transporters are expressed in human platelets. | 6.79e-05 | 2 | 287 | 2 | 16198020 | |
| Pubmed | Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression. | 6.79e-05 | 2 | 287 | 2 | 33588886 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 23826352 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 29335275 | ||
| Pubmed | SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer. | 6.79e-05 | 2 | 287 | 2 | 33665967 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 18281474 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 24105476 | ||
| Pubmed | EMC1 RUSC1 LAMC3 MBOAT2 NUP210 MAN2B2 GRAMD1A TXNDC12 CCDC142 SLC7A3 APH1A FAM210B MAN1B1 | 6.80e-05 | 430 | 287 | 13 | 16303743 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | EMC1 IFT172 NCLN PFKP FASN PTPRD PTPRF PTPRN2 NUP210 PEX2 PYCR1 GNAS SPTLC2 ACAD9 GRAMD1A APOA1 PPEF1 PTOV1 ANKRD13A NUP93 MAN1B1 | 6.85e-05 | 974 | 287 | 21 | 28675297 |
| Interaction | TOP3B interactions | VWA5B2 TRNP1 SPHK2 EPPK1 SREBF1 IPP EML2 LAMC3 RCC1 NCLN PFKP ABCA7 ADCY7 JAK3 FASN PHLDB1 PTPRF KCNG1 NBEAL2 MCM3AP PKD1 WDR90 GNAS PREX1 MED12 ABCC10 TBCD NLRX1 TEP1 DHX30 CCDC142 TRAF4 CELSR1 THADA C2CD3 CELSR3 MEGF8 NISCH CSPG4 HPS6 ANKRD34A ZFYVE26 TANC1 LRBA SYVN1 EXOC4 | 1.39e-07 | 1470 | 278 | 46 | int:TOP3B |
| Interaction | PTPRO interactions | EMC1 CYP51A1 NCLN B3GAT3 PTPRF NUP210 GRAMD1A DPYSL4 TXNDC12 ANKRD13A MAN1B1 | 4.88e-06 | 143 | 278 | 11 | int:PTPRO |
| Interaction | TTYH1 interactions | SLC16A13 TMEM219 CYP51A1 ABCA7 ADCY6 PGAP1 DAGLA ABCC10 LRRC8C CERK GRAMD1A GJC1 SLC7A3 KCNT2 FAM210B | 1.97e-05 | 300 | 278 | 15 | int:TTYH1 |
| Interaction | BSG interactions | MYH9 SLC16A13 EMC1 PDLIM7 NCLN PFKP FASN NOP9 COG6 TPP1 NBEAL2 CLTC GNAS TBCD VMP1 CACNA1C ABCC1 FLOT2 NLRX1 RIF1 NUP93 SYVN1 EXOC4 | 2.39e-05 | 631 | 278 | 23 | int:BSG |
| Interaction | LOC254896 interactions | 2.59e-05 | 43 | 278 | 6 | int:LOC254896 | |
| Interaction | LGALS8 interactions | DAG1 ADCY6 CLCN5 PAN2 PDIA2 SDK1 LRRC8C ABCC1 DNAJC13 SLC1A1 CSPG4 | 3.12e-05 | 174 | 278 | 11 | int:LGALS8 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | LINGO3 ISLR PXDN HMCN2 PTPRD PTPRF PXDNL SDK1 SIGLEC12 SDK2 MXRA5 SIGLEC11 SIGLEC1 | 3.03e-08 | 161 | 201 | 13 | 593 |
| GeneFamily | WD repeat domain containing | NBEAL1 IFT172 WDR18 EML2 WDFY2 DCAF5 NBEAL2 FBXW5 WDR90 NBEA TEP1 WDR19 LLGL1 TLE3 WDR45B LRBA | 4.03e-08 | 262 | 201 | 16 | 362 |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.79e-06 | 9 | 201 | 4 | 1230 | |
| GeneFamily | Potassium voltage-gated channels | 7.75e-05 | 40 | 201 | 5 | 274 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.53e-04 | 10 | 201 | 3 | 53 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 2.46e-04 | 28 | 201 | 4 | 745 | |
| GeneFamily | ATP binding cassette subfamily C | 3.57e-04 | 13 | 201 | 3 | 807 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.66e-04 | 3 | 201 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.66e-04 | 3 | 201 | 2 | 1189 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.55e-03 | 21 | 201 | 3 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 2.11e-03 | 160 | 201 | 7 | 555 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.91e-03 | 26 | 201 | 3 | 253 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | VWA5B2 TRNP1 MAB21L4 PFKP PTPRN2 ABCC8 PKD1 SLC38A11 BAIAP3 SDK1 SLC29A4 VSTM2A KLC2 NBEA TUT1 NEURL1 STON2 | 5.16e-06 | 429 | 284 | 17 | M45694 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | EPPK1 SPO11 LINGO3 LAMC3 ADGRV1 ADCY7 TMCO4 KCNG1 ABCC8 DMGDH FLOT2 NLRX1 ARTN AQP3 SLC1A1 RAX THBD CSPG4 TACSTD2 | 8.79e-06 | 544 | 284 | 19 | M1936 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | EPPK1 SPO11 LINGO3 LAMC3 ADGRV1 ADCY7 TMCO4 KCNG1 ABCC8 DMGDH FLOT2 NLRX1 ARTN AQP3 SLC1A1 RAX THBD CSPG4 TACSTD2 | 1.86e-05 | 574 | 284 | 19 | MM820 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SLC16A13 SELENOS EPPK1 EMC1 SREBF1 DAG1 NCLN ADCY6 PXDN PTPRF MFSD1 ABCC1 SPTLC2 GJC1 TUT1 TMBIM6 SERPINH1 THBD SF3B3 NISCH SYVN1 | 1.94e-05 | 681 | 284 | 21 | M5314 |
| Coexpression | GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN | 2.18e-05 | 139 | 284 | 9 | M8919 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SLC16A13 SELENOS EPPK1 EMC1 SREBF1 DAG1 NCLN ADCY6 PXDN PTPRF MFSD1 ABCC1 SPTLC2 GJC1 TUT1 TMBIM6 SERPINH1 THBD SF3B3 NISCH SYVN1 | 3.08e-05 | 703 | 284 | 21 | MM1055 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.93e-05 | 196 | 284 | 10 | M3008 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | TMEM219 WDR18 ABCA7 WDFY2 TBCD CERK MSRB2 TLE3 FAM210B MAN1B1 | 6.46e-05 | 198 | 284 | 10 | M6114 |
| Coexpression | GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN | RELN EMC1 ABCA7 ADCY6 ALG14 PGAP1 PKD1 DEAF1 HMGXB4 CACNA2D4 | 6.73e-05 | 199 | 284 | 10 | M3384 |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_HSC_DN | 6.73e-05 | 199 | 284 | 10 | M7036 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 7.02e-05 | 200 | 284 | 10 | M4667 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP | SLC16A13 ISLR APOBR WDFY2 PXDN PYCR1 ADCY4 NXN TXNDC12 WDR45B | 7.02e-05 | 200 | 284 | 10 | M7515 |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | RAPGEF5 RUSC1 EML2 EFR3A PARP4 TRANK1 SPTLC2 GTPBP2 ZFYVE26 MX2 | 7.02e-05 | 200 | 284 | 10 | M8972 |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | CCNK FASN WDR90 HELQ ANKRD13A RIF1 INTS13 ZFYVE26 MFSD13A EXOC4 | 7.02e-05 | 200 | 284 | 10 | M6653 |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_UP | 7.02e-05 | 200 | 284 | 10 | M3153 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 8.72e-05 | 166 | 284 | 9 | M6826 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | NBEAL1 LAMC3 ISLR KCNC4 PXDNL SLC38A11 ADGRD1 FAT4 MXRA5 GJC1 SLC6A12 ZBED6 | 6.17e-09 | 197 | 286 | 12 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWA5B2 RELN PTPRF KCNB1 PTPRN2 FAM151A ABCC8 BAIAP3 SDK2 MLXIPL NISCH | 4.03e-08 | 188 | 286 | 11 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN PTPRF KCNB1 PTPRN2 FAM151A ABCC8 CLTC NBEA MLXIPL RIF1 NISCH | 5.86e-08 | 195 | 286 | 11 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN PTPRF KCNB1 PTPRN2 FAM151A ABCC8 CLTC NBEA MLXIPL RIF1 NISCH | 5.86e-08 | 195 | 286 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LAMC3 ISLR PXDN PXDNL SLC38A11 MXRA5 GJC1 PPEF1 SERPINH1 SMTN CSPG4 | 6.17e-08 | 196 | 286 | 11 | 40e6900a0d56088a40d37ec312f53207ea952602 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LAMC3 ISLR PXDN PXDNL SLC38A11 MXRA5 GJC1 PPEF1 SERPINH1 SMTN CSPG4 | 6.17e-08 | 196 | 286 | 11 | 0b247cf981981ae61aca5de82ef687e8d783c9ef |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LAMC3 ISLR PXDNL SLC38A11 ADCY4 MXRA5 GJC1 PPEF1 SERPINH1 SMTN CSPG4 | 6.17e-08 | 196 | 286 | 11 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LAMC3 ISLR PXDN PXDNL SLC38A11 ADCY4 MXRA5 GJC1 SERPINH1 SMTN CSPG4 | 6.17e-08 | 196 | 286 | 11 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LAMC3 ISLR PXDNL SLC38A11 ADCY4 MXRA5 GJC1 PPEF1 SERPINH1 SMTN CSPG4 | 6.50e-08 | 197 | 286 | 11 | 12370ee857fddf1cf26196b23c21b68dcea48eb3 |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | IPP GPR179 ABCC8 PAN2 BAIAP3 FAM135A CACNA1C CALCA NLRX1 AASDH | 2.33e-07 | 177 | 286 | 10 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | VWA5B2 MAB21L4 PIWIL1 ADGRV1 SLC38A11 BAIAP3 SLC29A4 MLXIPL CELSR3 NEURL1 | 2.58e-07 | 179 | 286 | 10 | d70791d2a0db35a6b013fa7ed2f9f39364581eff |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | VWA5B2 TRNP1 MAB21L4 ABCC8 SLC38A11 ALOX15B VSTM2A PPEF1 NEURL1 ATP12A | 2.58e-07 | 179 | 286 | 10 | 06f92c884189197c86793191c05f65e34925c097 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | VWA5B2 TRNP1 MAB21L4 ABCC8 SLC38A11 BAIAP3 SLC29A4 ADAM29 MLXIPL EPHA10 | 2.72e-07 | 180 | 286 | 10 | 6b1606238417490e0d9930870a7827419d1c3737 |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | VWA5B2 ABCC8 PDIA2 SLC38A11 SLC29A4 CALCA VSTM2A FAM135B CELSR3 NEURL1 | 4.70e-07 | 191 | 286 | 10 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.93e-07 | 192 | 286 | 10 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.93e-07 | 192 | 286 | 10 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LAMC3 ISLR PXDNL SLC38A11 MXRA5 GJC1 PPEF1 SERPINH1 SMTN CSPG4 | 6.23e-07 | 197 | 286 | 10 | 983502a99e6d59bb36225b0246a9990604de1a01 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PDLIM7 LAMC3 ISLR SLC38A11 MXRA5 GJC1 PPEF1 SERPINH1 SMTN CSPG4 | 6.23e-07 | 197 | 286 | 10 | 4a04da876a1482604452ae53c124ae68eda0bd5e |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | EPPK1 MAB21L4 PXDNL SLC39A5 LAMA3 VWA1 AASS TACSTD2 CDH3 EPHA10 | 6.84e-07 | 199 | 286 | 10 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.74e-07 | 160 | 286 | 9 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 170 | 286 | 9 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 170 | 286 | 9 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 170 | 286 | 9 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | LA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.79e-06 | 128 | 286 | 8 | 071becbe97598c2b65580b0989eb664d6fd6c85a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-06 | 173 | 286 | 9 | 0ba64e5385fe714f876002520f8b5202809bf11e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | VWA5B2 MAB21L4 KCNC4 ABCC8 PDIA2 SLC38A11 BAIAP3 VSTM2A EPHA10 | 2.05e-06 | 175 | 286 | 9 | 9941c35601134d88d1b3249c81f8b43a8fc61610 |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-06 | 175 | 286 | 9 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.05e-06 | 175 | 286 | 9 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-06 | 175 | 286 | 9 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-06 | 180 | 286 | 9 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | VWA5B2 MAB21L4 ABCC8 SLC38A11 BAIAP3 SLC29A4 MLXIPL CELSR3 NEURL1 | 2.83e-06 | 182 | 286 | 9 | 0e589bf97d51b4b2f723f8c45853ad81b7ce8778 |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | MAB21L4 DNAAF3 PTPRF KLHL13 LAMA3 SLC1A1 KCNT2 TACSTD2 HYDIN | 2.83e-06 | 182 | 286 | 9 | ab15316cff989b61ff397a866d7ca8b49c13e981 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.83e-06 | 182 | 286 | 9 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 184 | 286 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 184 | 286 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 184 | 286 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.24e-06 | 185 | 286 | 9 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.24e-06 | 185 | 286 | 9 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 186 | 286 | 9 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.53e-06 | 187 | 286 | 9 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.53e-06 | 187 | 286 | 9 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.69e-06 | 141 | 286 | 8 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 189 | 286 | 9 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | VWA5B2 TRNP1 ADGRV1 ABCC8 SLC38A11 BAIAP3 CALCA VSTM2A FAM135B | 4.02e-06 | 190 | 286 | 9 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-06 | 190 | 286 | 9 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_NE_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | VWA5B2 MAB21L4 PTPRF ABCC8 SLC38A11 BAIAP3 SLC29A4 VSTM2A NEURL1 | 4.20e-06 | 191 | 286 | 9 | f0a81f621e63e87ff62224b33cf0c71dfac1d6e2 |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 191 | 286 | 9 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-06 | 192 | 286 | 9 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.38e-06 | 192 | 286 | 9 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.38e-06 | 192 | 286 | 9 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.57e-06 | 193 | 286 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|metastatic_Brain / Location, Cell class and cell subclass | 4.76e-06 | 194 | 286 | 9 | d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.76e-06 | 194 | 286 | 9 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | VWA5B2 RAPGEF5 MAB21L4 ADGRV1 ABCC8 SLC38A11 BAIAP3 VSTM2A CELSR1 | 4.76e-06 | 194 | 286 | 9 | b30379f8dc41c86c746af9930541fbb4819d8fa0 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.18e-06 | 196 | 286 | 9 | 9a420a4eb46cb554bec641726fea5398ff60f630 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.40e-06 | 197 | 286 | 9 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.40e-06 | 197 | 286 | 9 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.86e-06 | 199 | 286 | 9 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 199 | 286 | 9 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.86e-06 | 199 | 286 | 9 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 5.86e-06 | 199 | 286 | 9 | f89d67e3d8cd48ef5c30a5ad71764f4ebbc8bcb3 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 5.86e-06 | 199 | 286 | 9 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 6.10e-06 | 200 | 286 | 9 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.10e-06 | 200 | 286 | 9 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.10e-06 | 200 | 286 | 9 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.10e-06 | 200 | 286 | 9 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4-L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.10e-06 | 200 | 286 | 9 | e2ced6eb1de9a526c34c7558b9c637854916e624 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.10e-06 | 200 | 286 | 9 | 9bc924755e5a4c464408e6103b86bf1b4e8c58b5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.28e-06 | 108 | 286 | 7 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.80e-06 | 161 | 286 | 8 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 9.80e-06 | 161 | 286 | 8 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 162 | 286 | 8 | 9f568836199a05f696294caac1ea3fa413984423 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 164 | 286 | 8 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 169 | 286 | 8 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.45e-05 | 170 | 286 | 8 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 170 | 286 | 8 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-05 | 173 | 286 | 8 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-05 | 173 | 286 | 8 | 46ed379571385684145b5cb6dd4ae340ac546e64 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-05 | 174 | 286 | 8 | 019eae059bd9eb107dee8f0d0f574ca36c2c26e1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 176 | 286 | 8 | ef0ff02897104e938c8a632357d8f1a6f014e68a | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.87e-05 | 176 | 286 | 8 | 581d78811b2d99f38a2c7cc268aeb1cf932379c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 176 | 286 | 8 | da0983929fa682a68e536c298a2d7add188b7563 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 1.87e-05 | 176 | 286 | 8 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.95e-05 | 177 | 286 | 8 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-05 | 178 | 286 | 8 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 179 | 286 | 8 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 180 | 286 | 8 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 180 | 286 | 8 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-05 | 180 | 286 | 8 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | Thalamus-Macroglia|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.29e-05 | 181 | 286 | 8 | 4f62b63854a4e9fea6e839f0340e78392c66fb0e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 181 | 286 | 8 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.29e-05 | 181 | 286 | 8 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.29e-05 | 181 | 286 | 8 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-05 | 181 | 286 | 8 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-05 | 182 | 286 | 8 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 182 | 286 | 8 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 182 | 286 | 8 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 182 | 286 | 8 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-05 | 182 | 286 | 8 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.47e-05 | 183 | 286 | 8 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| Drug | verapamil | MYH9 ABCB7 ABCA7 ADCY6 ADCY7 CHRNA4 KCNB1 KCNC3 KCNC4 KCNG1 PKD1 ABCC10 CACNA1C ABCC1 ADCY4 APOA1 ABCG1 CACNA2D4 CACNG6 KCNT2 KCNG4 SEC23IP MX2 | 5.50e-08 | 490 | 282 | 23 | CID000002520 |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | PDLIM7 DAG1 EML2 ADCY6 NBEAL2 NUP210 CERK SPTLC2 LAMA3 ARTN SMTN PTOV1 TRAF4 NISCH | 1.50e-07 | 194 | 282 | 14 | 7446_DN |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | SPHK2 EMC1 ADCY7 KCNG1 TPP1 NBEAL2 MED6 SPTLC2 KLC2 LAMA3 ARTN TEP1 TLE3 ZFYVE26 | 1.60e-07 | 195 | 282 | 14 | 5447_DN |
| Drug | mepyramine | ADCY6 ADCY7 NOP9 PTPRN2 ABCC8 GNAS ALOX15B ADCY4 CALCA AASDH ARG1 | 3.64e-06 | 154 | 282 | 11 | CID000004992 |
| Drug | glibenclamide | ABCB7 ABCA7 ADCY6 ADCY7 CLCN5 KCNB1 ABCC8 ABCC10 CACNA1C ABCC1 ADCY4 CALCA PEX3 APOA1 ABCG1 CACNA2D4 LRBA | 6.34e-06 | 382 | 282 | 17 | CID000003488 |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | MBOAT2 JAK3 CLCN5 NBEAL2 PGAP1 TBCD SPTLC2 ARTN SMTN THBD TLE3 PRKX | 6.85e-06 | 197 | 282 | 12 | 2638_DN |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; HL60; HT_HG-U133A | PDLIM7 EML2 NCLN CLCN5 SPTLC2 DUSP8 TEP1 ARG1 MSRB2 SF3B3 TLE3 MAN1B1 | 7.60e-06 | 199 | 282 | 12 | 3115_DN |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; HL60; HT_HG-U133A | PDLIM7 SIGLEC8 CCNK PTPRN2 KLC2 NBEA AQP3 MSR1 MLXIPL RIF1 TRAF4 ATP12A | 7.99e-06 | 200 | 282 | 12 | 2141_UP |
| Drug | AC1L9NB5 | 1.22e-05 | 25 | 282 | 5 | CID000449609 | |
| Disease | Kidney Failure, Chronic | 5.83e-06 | 48 | 278 | 6 | C0022661 | |
| Disease | Profound Mental Retardation | 5.45e-05 | 139 | 278 | 8 | C0020796 | |
| Disease | Mental deficiency | 5.45e-05 | 139 | 278 | 8 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 5.45e-05 | 139 | 278 | 8 | C0025363 | |
| Disease | phosphoglycerides measurement | 8.80e-05 | 48 | 278 | 5 | EFO_0022291 | |
| Disease | phosphatidylcholine measurement | IFT172 ABCC8 ALG14 YDJC DAGLA MYO1H APOA1 TUT1 MLXIPL MALRD1 NUP93 | 8.83e-05 | 284 | 278 | 11 | EFO_0010226 |
| Disease | X-23636 measurement | 8.84e-05 | 2 | 278 | 2 | EFO_0800852 | |
| Disease | Hepatic fibrosis | 9.73e-05 | 49 | 278 | 5 | HP_0001395 | |
| Disease | Intellectual Disability | FASN TPP1 ALG14 PYCR1 GNAS TBCD CNDP1 DEAF1 CALCA NBEA GTPBP2 AASS WDR45B MAN1B1 | 9.90e-05 | 447 | 278 | 14 | C3714756 |
| Disease | Colorectal Carcinoma | IPP EML2 ISLR PTPRD PTPRN2 ABCC8 MCM3AP PAN2 GNAS ABCC1 ADAM29 NXN SMTN ABCG1 INTS13 NEURL1 ACSL5 EXOC4 | 1.35e-04 | 702 | 278 | 18 | C0009402 |
| Disease | hereditary spastic paraplegia 28 (implicated_via_orthology) | 2.64e-04 | 3 | 278 | 2 | DOID:0110779 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia 54 (implicated_via_orthology) | 2.64e-04 | 3 | 278 | 2 | DOID:0110806 (implicated_via_orthology) | |
| Disease | cortical thickness | VWA5B2 RELN NBEAL1 SREBF1 EML2 LAMC3 ADGRV1 BBS9 DNAAF3 PHLDB1 PTPRF PKD1 NAV3 ABCC10 VMP1 FLOT2 DPYSL4 ABCG1 CELSR1 THADA GTPBP2 MALRD1 EXOC4 | 3.90e-04 | 1113 | 278 | 23 | EFO_0004840 |
| Disease | Disorder of eye | 9.52e-04 | 212 | 278 | 8 | C0015397 | |
| Disease | GlcNAc sulfate conjugate of C21H34O2 steroid measurement | 1.29e-03 | 6 | 278 | 2 | EFO_0800663 | |
| Disease | Zellweger syndrome (implicated_via_orthology) | 1.29e-03 | 6 | 278 | 2 | DOID:905 (implicated_via_orthology) | |
| Disease | galectin-3-binding protein measurement | 1.29e-03 | 6 | 278 | 2 | EFO_0010241 | |
| Disease | pregnenediol sulfate (C21H34O5S) measurement | 1.29e-03 | 6 | 278 | 2 | EFO_0800299 | |
| Disease | Neuronal Ceroid-Lipofuscinoses | 1.29e-03 | 6 | 278 | 2 | C0027877 | |
| Disease | sphingomyelin measurement | 1.37e-03 | 278 | 278 | 9 | EFO_0010118 | |
| Disease | choline measurement | 1.49e-03 | 130 | 278 | 6 | EFO_0010116 | |
| Disease | Brain Diseases | 1.63e-03 | 25 | 278 | 3 | C0006111 | |
| Disease | Stage IV Skin Melanoma | 1.80e-03 | 7 | 278 | 2 | C1321872 | |
| Disease | Encephalopathies | 2.05e-03 | 27 | 278 | 3 | C0085584 | |
| Disease | cholesteryl ester 14:0 measurement | 2.05e-03 | 27 | 278 | 3 | EFO_0010340 | |
| Disease | Major Depressive Disorder | 2.25e-03 | 243 | 278 | 8 | C1269683 | |
| Disease | susceptibility to rheumatic fever measurement | 2.28e-03 | 28 | 278 | 3 | EFO_0008416 | |
| Disease | sialic acid-binding Ig-like lectin 6 measurement | 2.39e-03 | 8 | 278 | 2 | EFO_0008285 | |
| Disease | peroxisomal biogenesis disorder (is_implicated_in) | 2.39e-03 | 8 | 278 | 2 | DOID:0080377 (is_implicated_in) | |
| Disease | blood vanadium measurement | 2.78e-03 | 30 | 278 | 3 | EFO_0021533 | |
| Disease | mean arterial pressure | SLC17A2 CEP170 PTPRD TLE5 PXDNL GNAS PREX1 ABCC10 NXN THADA LRBA ATP12A | 2.95e-03 | 499 | 278 | 12 | EFO_0006340 |
| Disease | Mental Depression | 2.95e-03 | 254 | 278 | 8 | C0011570 | |
| Disease | Mental deterioration | 3.05e-03 | 9 | 278 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 3.05e-03 | 9 | 278 | 2 | C1270972 | |
| Disease | Hirschsprung Disease | 3.06e-03 | 31 | 278 | 3 | C0019569 | |
| Disease | Unipolar Depression | 3.32e-03 | 259 | 278 | 8 | C0041696 | |
| Disease | cesarean section, Self-injurious behavior | 3.35e-03 | 32 | 278 | 3 | EFO_0009636, HP_0100716 | |
| Disease | acute necrotizing pancreatitis (implicated_via_orthology) | 3.79e-03 | 10 | 278 | 2 | DOID:0080998 (implicated_via_orthology) | |
| Disease | Ciliopathies | 3.92e-03 | 110 | 278 | 5 | C4277690 | |
| Disease | estradiol measurement | 3.92e-03 | 110 | 278 | 5 | EFO_0004697 | |
| Disease | pit and fissure surface dental caries | 4.33e-03 | 35 | 278 | 3 | EFO_0006338 | |
| Disease | obesity (implicated_via_orthology) | 4.44e-03 | 215 | 278 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | conotruncal heart malformations | 4.56e-03 | 114 | 278 | 5 | MONDO_0016581 | |
| Disease | PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) | 4.60e-03 | 11 | 278 | 2 | C4721541 | |
| Disease | epilepsy, response to xenobiotic stimulus | 4.60e-03 | 11 | 278 | 2 | EFO_0000474, GO_0009410 | |
| Disease | Jeune thoracic dystrophy | 4.60e-03 | 11 | 278 | 2 | C0265275 | |
| Disease | cognitive function measurement | RAPGEF5 PDLIM7 LAMC3 EFR3A PTPRD PTPRF KCNB1 KCNC4 PTPRN2 CD163L1 SDK1 PREX1 CACNA1C FLOT2 GJC1 NBEA TMBIM6 FAM135B WDR19 THBD GALNTL5 HYDIN ACSL5 EXOC4 | 4.86e-03 | 1434 | 278 | 24 | EFO_0008354 |
| Disease | hyperinsulinism (is_implicated_in) | 5.48e-03 | 12 | 278 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | Depressive disorder | 6.36e-03 | 289 | 278 | 8 | C0011581 | |
| Disease | Zellweger Spectrum | 6.44e-03 | 13 | 278 | 2 | C3658299 | |
| Disease | Zellweger-Like Syndrome | 6.44e-03 | 13 | 278 | 2 | C0751594 | |
| Disease | Infantile Refsum Disease (disorder) | 6.44e-03 | 13 | 278 | 2 | C0282527 | |
| Disease | Depressed mood | 6.44e-03 | 13 | 278 | 2 | C0344315 | |
| Disease | age-related macular degeneration, disease progression measurement | 6.77e-03 | 41 | 278 | 3 | EFO_0001365, EFO_0008336 | |
| Disease | calcium measurement | SREBF1 MBOAT2 TLE5 PTPRN2 GNAS POLK ABCC10 SIGLEC12 NLRX1 GRAMD1A MLXIPL KCNT2 TLE3 | 6.99e-03 | 628 | 278 | 13 | EFO_0004838 |
| Disease | ceramide measurement | 7.13e-03 | 235 | 278 | 7 | EFO_0010222 | |
| Disease | volumetric bone mineral density | 7.24e-03 | 42 | 278 | 3 | EFO_0007620 | |
| Disease | Malformations of Cortical Development | 7.47e-03 | 14 | 278 | 2 | C1955869 | |
| Disease | trimethylamine-N-oxide measurement | 7.47e-03 | 14 | 278 | 2 | EFO_0010541 | |
| Disease | cystic fibrosis associated meconium ileus | 7.47e-03 | 14 | 278 | 2 | EFO_0004608 | |
| Disease | Impaired cognition | 7.47e-03 | 14 | 278 | 2 | C0338656 | |
| Disease | Saldino-Noonan Syndrome | 7.47e-03 | 14 | 278 | 2 | C0036069 | |
| Disease | Cortical Dysplasia | 7.47e-03 | 14 | 278 | 2 | C0431380 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 7.47e-03 | 14 | 278 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 7.73e-03 | 43 | 278 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | cognitive impairment measurement | 8.24e-03 | 44 | 278 | 3 | EFO_0007998 | |
| Disease | age at diagnosis, osteonecrosis | 8.24e-03 | 44 | 278 | 3 | EFO_0004259, EFO_0004918 | |
| Disease | Peroxisome biogenesis disorders | 8.56e-03 | 15 | 278 | 2 | C1832200 | |
| Disease | myeloid cell surface antigen CD33 measurement | 8.56e-03 | 15 | 278 | 2 | EFO_0008238 | |
| Disease | response to olanzapine | 8.56e-03 | 15 | 278 | 2 | GO_0097333 | |
| Disease | unipolar depression, response to escitalopram, response to citalopram, mood disorder | 8.56e-03 | 15 | 278 | 2 | EFO_0003761, EFO_0004247, EFO_0006329, EFO_0007871 | |
| Disease | third ventricle volume measurement | 8.56e-03 | 15 | 278 | 2 | EFO_0010335 | |
| Disease | Adrenoleukodystrophy, Neonatal | 8.56e-03 | 15 | 278 | 2 | C0282525 | |
| Disease | lipoprotein measurement, phospholipid measurement | 8.60e-03 | 85 | 278 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | mean reticulocyte volume | SPHK2 MYH9 ABCB7 ABCA7 PTPRF PREX1 ABCC10 ABCC1 FLOT2 NLRX1 MLXIPL THADA SEC23IP NR5A1 CDH3 | 9.25e-03 | 799 | 278 | 15 | EFO_0010701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| THRLAGLLSRSGGVV | 91 | P06881 | |
| SHLFTTLGLRGLSGI | 286 | Q9UKF5 | |
| LQTALLRSSGSLGHR | 456 | Q5SW79 | |
| LLLLGTGLLRASSHV | 16 | P43681 | |
| VSGLLAASGLLFTHL | 121 | O94766 | |
| ETLLNLGVSGSRIHL | 851 | Q8NHU2 | |
| SLLLGGLDAEASRHL | 321 | Q6UVK1 | |
| VLTHLRITSHIGIGL | 421 | P45844 | |
| SQRGRSGFLSHLLLL | 396 | O94812 | |
| LELARGHQVALSSIS | 556 | Q6QNK2 | |
| VLSGLGLSTLHLILA | 261 | O43306 | |
| ATSALQQGLRGLHLS | 366 | Q13202 | |
| ALLTELGRLQAHEGS | 6 | Q9Y3Q7 | |
| TGIAGTTREHLGLAL | 291 | Q9BX10 | |
| TLEGHLRSILGTLTV | 106 | Q14254 | |
| LHFLRIASSQLTGLG | 3731 | Q6V0I7 | |
| IALTGLQHAGRILTT | 436 | Q9H845 | |
| IYGISSAHTLLRGTL | 711 | Q9UDR5 | |
| GIATLIEGTSLTFHI | 621 | Q8IZF3 | |
| SGSLGAHINATLTVL | 1956 | Q8WXG9 | |
| GTRLGLHYDTLATGI | 61 | O75909 | |
| GRVHITGATLALLAG | 406 | Q8NFM4 | |
| ILTHGIRFSLQGALQ | 591 | Q17RM4 | |
| LSATTSLRVLALGGE | 306 | Q4L235 | |
| LTLAVLFLTGSQARH | 6 | P02647 | |
| RALRSATQHTGTLFG | 2136 | Q9NYQ6 | |
| VVAGSGGHTTEILRL | 41 | Q96F25 | |
| GGHTTEILRLLGSLS | 46 | Q96F25 | |
| GAVSTASHLLVLGSL | 151 | P51828 | |
| SSGHLALILSSIFGL | 1356 | Q9NR16 | |
| LLNSVIGRALGISHA | 56 | Q7L2E3 | |
| ALLTLGLNLSHLGRA | 2706 | Q75N90 | |
| LVHSRAGSGLVLSGS | 466 | Q6W2J9 | |
| SGLLLLVSLEVFRHS | 181 | Q9BXT2 | |
| THTLDISQLGDLGTR | 416 | Q14156 | |
| LSGRLLINSVFHVGA | 366 | Q96CP6 | |
| TVLGGASAHRTLAGL | 111 | Q8IZY2 | |
| GRISLVLGGDHSLAI | 91 | P05089 | |
| RRGSGTLLLDHISQT | 406 | Q69YU3 | |
| SVLLGSRGLDISHIS | 61 | Q8N1F7 | |
| VTGSIQGFLSIRDLH | 2601 | Q6ZS30 | |
| VLSVSSGGQHTVLLV | 401 | P18754 | |
| DVAGGALTHSLLLTR | 21 | Q9H8K7 | |
| VLGHAARLASSGLLL | 6 | Q96AA3 | |
| LSFILIHLVLSSVSG | 11 | Q6IE38 | |
| VSSLHQARSGLGVTV | 326 | Q9Y573 | |
| GTFLLVGLSRPHSSL | 436 | P52333 | |
| GGEIFLHVLSSSRSI | 381 | Q9NVM9 | |
| LDTVGRGSSLHLHVS | 311 | Q969V3 | |
| EVHRLSATLGGLLQD | 391 | Q92932 | |
| ALHVLESGGFRSLLI | 241 | P32322 | |
| GQGRLLSLLDDSSLH | 86 | Q15334 | |
| VLTGNLIASLAHSRA | 1231 | Q7Z5J8 | |
| GRTLLHLAVSLGHLE | 41 | Q8IZ07 | |
| TALQLGQSSLVLGHR | 311 | Q8TEM1 | |
| LGSLQGHRLDSLSIL | 261 | Q08AI8 | |
| HLADTLAGLSVLRAT | 1106 | Q5T3U5 | |
| VVHILDSRTGGSLVA | 856 | Q504Q3 | |
| THGSFVVRTLLQVLG | 201 | Q86U38 | |
| NIGGAHFTTRLSTLR | 56 | Q96MP8 | |
| VIDTNLTTLRDGLHG | 2261 | Q16787 | |
| TSSFIRHVVATLLGL | 51 | Q6ZWT7 | |
| GASHLQLALQATRTG | 156 | Q6PRD1 | |
| SLSGRTKLLHQTGLS | 16 | Q9NTX5 | |
| QRTLLHGSGHTLRIS | 3366 | Q8NDA2 | |
| GLVVGSHLLTSGLTF | 191 | Q96BI3 | |
| HDLSLASLLGAGALR | 161 | Q5T4W7 | |
| TGDRTIIGHIASLAS | 276 | P54707 | |
| LLTAATTGILRHIAA | 1121 | O60318 | |
| ARHSLGLQTLGLTVR | 351 | Q8TDN1 | |
| ISVSATRLGANGSHI | 131 | Q14118 | |
| HLSAAGLSTGALLAI | 631 | Q86UP0 | |
| IRTVAAGALASLSHL | 86 | O14498 | |
| ISFIGHSLGNLIIRS | 1321 | Q9P2D6 | |
| LTETSLISGNLHRIG | 196 | Q969U6 | |
| LLLGGLILLHSSSNV | 3891 | Q9NYQ8 | |
| QFLTHIGLGVTLRAA | 141 | Q9H2C5 | |
| RTHSINALLIIGGFE | 496 | Q01813 | |
| GKFATLTERLLGIHS | 161 | P28328 | |
| SSIQHLLGDGLTELI | 166 | P56589 | |
| LSGLTTGTHEVQSLL | 1386 | Q8IVL0 | |
| VSLHIGISLISLGIF | 101 | Q96KR6 | |
| STILQLHAGVSERSG | 441 | Q96JK2 | |
| SIAGHSLGSLILFDI | 346 | O94830 | |
| AGHTLTARRGLSLLL | 1621 | Q7Z7M0 | |
| TAIRSDSTHLVTLGG | 291 | Q9P2J3 | |
| FLSRTLLGSHGQELL | 1821 | P50851 | |
| LTALSGESLGHLRSL | 186 | P0C6S8 | |
| GSLRGLNLTSLSVTH | 241 | P0C6S8 | |
| SQARHGAGTRLALLL | 56 | Q8TDT2 | |
| ALLGSAGHTTLGITL | 201 | Q9H3U5 | |
| EATAGFTIGRVLHTL | 446 | Q93074 | |
| LARHSLGLQTLGLTA | 356 | Q9UIX4 | |
| HLLGINVTDFTRGIL | 376 | P35579 | |
| LEHNGTVSGALLLAI | 421 | Q96KJ4 | |
| LVTLGASSLREERGH | 71 | Q8N319 | |
| TLITLLVHTSRGQEG | 456 | Q6UVM3 | |
| GLDLGDLSRFLVTHS | 241 | Q13087 | |
| LGISLAEHREALLSG | 976 | Q5JZY3 | |
| LGESLSLIGHRLQET | 531 | Q9UGU5 | |
| RILLLVAAATGTHAE | 6 | A0A0G2JMI3 | |
| EGLAGNTSVTHLSLL | 801 | Q86UT6 | |
| NGTILGLISLDSRLH | 41 | Q96R45 | |
| ARGSRNILLVSDGHL | 966 | Q9UKK3 | |
| AGSVLSTAHGSLLNL | 11 | Q9BZM2 | |
| TGQSRSFRILAHLTG | 161 | Q9NR12 | |
| HFLGGARITVLASKT | 581 | Q3SYG4 | |
| STIRILGGLLSAYHL | 331 | Q9UKM7 | |
| RSHSILLQFSISGGI | 1876 | P78509 | |
| THLIREGSSAQALAL | 1451 | Q9UG01 | |
| GLGEAQVILALSSHL | 71 | Q9H0B6 | |
| LLQLSTLFSSVQGHG | 156 | P21757 | |
| NGTILGLISLDSRLH | 41 | O95047 | |
| LTLGGLAVSEHRLSN | 76 | Q86YD1 | |
| RATHLLVLTARDGGL | 196 | Q9H158 | |
| GTLLSQRSFIALDHL | 406 | Q5VYJ5 | |
| VEGQHTVLSSGTLRI | 461 | A1KZ92 | |
| HTISGIVGNSATALL | 386 | Q9Y2V7 | |
| HLTCLLSSGDLQVTG | 316 | O14531 | |
| LLHRSQTGVGELTTQ | 931 | Q96A65 | |
| LKAGETFGRLTLHNT | 4896 | Q4G0P3 | |
| SLALGSLHRYLGGIS | 911 | Q86XA9 | |
| VVHLSGSFEVISGRL | 121 | Q5T6J7 | |
| RSDTTHLVTLGGVLR | 336 | Q9P2N7 | |
| ARHSTGLQSLGFTLR | 311 | Q14721 | |
| NLSGAALRVHVVLSS | 1546 | Q4AC94 | |
| ALSLQAGLRTLHDIG | 1696 | Q13936 | |
| LLGSVDGRHLLRTLS | 51 | Q8N9W5 | |
| TSRTHDALIVGTLSG | 1966 | P17927 | |
| AASISGHVLSGRTAL | 121 | O75398 | |
| LLGHSTAGAIGRLLA | 516 | Q8WW52 | |
| RSNHLTSGVIEGLLS | 301 | Q96LA6 | |
| TRSHGILLGVVGSDV | 521 | Q7Z3S7 | |
| SEVLHGLIGRTQRSA | 201 | Q8TCT0 | |
| LHLGFGTIRDSLNSK | 251 | P36383 | |
| RLLLVLVSALSAGSH | 256 | Q8NGA4 | |
| LHISSSGTVISFGER | 3911 | Q8N3K9 | |
| LLSGSLAGLIDISAH | 136 | P51795 | |
| LIGLLLAGQHTSSTT | 311 | Q16850 | |
| GFSGQLRSLLQHSLS | 496 | Q6NUI2 | |
| GLIRARLIGASHASG | 206 | Q7Z4T8 | |
| HRLLLLGAGESGKST | 41 | P63092 | |
| IFVHGESLRSSLVGV | 571 | Q9ULC5 | |
| THFIQAGLLSALGSL | 51 | P55061 | |
| HGTGALVISSLLDFL | 521 | O75165 | |
| LSVHALSRLGGYLAE | 1581 | O75165 | |
| HADHITGSGLLRSLL | 81 | O95571 | |
| FLLITGSGSELHDLR | 591 | Q9UI17 | |
| LVLLSERAHGISSQG | 771 | Q9Y2E5 | |
| HSLGAGTAAILSFLL | 471 | Q9Y4D2 | |
| SLSTLHVLGLGVFDR | 146 | O95834 | |
| ITERGITSRHLLIGL | 851 | Q8N766 | |
| NLSISRISFIGHSLG | 1206 | Q49AJ0 | |
| GHSLVNSLIETGRID | 441 | Q8TDG4 | |
| VGRSLQHLFLNSSGL | 616 | Q6NUI6 | |
| VTRGSGRASHLLLDQ | 1826 | Q9NYQ7 | |
| TIFSLHLAGVSSILG | 146 | P00395 | |
| NTALHEATLLGLAGR | 676 | Q9NVP4 | |
| GLFHRAITQSGVITT | 246 | Q6UWW8 | |
| HRTLLEGSGLESIIS | 2481 | P49327 | |
| SGEASTSLGRTHVLL | 171 | Q86YV9 | |
| LLLDFGGTVSLLQSH | 281 | Q86YV9 | |
| ITSGLHSFGRRLTIS | 336 | Q7Z5N4 | |
| VLLSGGISDHNRRLT | 256 | Q58EX2 | |
| GRHFIIGLSTVTFTL | 96 | Q08AI6 | |
| HLGVKGTSSLELRFL | 2076 | Q6ZTR5 | |
| LLTLHITVLRGSGAA | 16 | B1AKI9 | |
| SDHISLSTGSILLGL | 296 | Q14CX5 | |
| TGTLLLTLIDVNDHG | 531 | P22223 | |
| LNHSSLLRAGGTQVL | 1291 | Q9C0B2 | |
| VGHLQSITGIALASI | 276 | Q8N815 | |
| DGLLFRVLARIHTGT | 366 | Q8WY07 | |
| GITTGVLVREHSNLS | 31 | P43005 | |
| VSQSRLGLSFHGISG | 96 | W6CW81 | |
| LGSVINSRVLTAVHG | 111 | O75586 | |
| SLAHGLSLLLVAVAV | 3556 | P98161 | |
| GSSAGGLQHLVSIRT | 1081 | P10586 | |
| NGAILGLISLDSRLH | 41 | Q8NGT9 | |
| NGTILGLISLDSRLH | 41 | A4D2G3 | |
| SRGTETHGLVQVTLL | 1471 | P23468 | |
| GGISETTDLNLLHRV | 286 | O14829 | |
| LFAVISRHSLSAGLV | 1216 | P33527 | |
| SRHSLSAGLVGLSVS | 1221 | P33527 | |
| SLFLVDHGILSGIQT | 286 | O15296 | |
| GHFLSVTGTVIRTSL | 121 | Q9NXL9 | |
| DATGTRVRGESHLLL | 336 | Q9NXL9 | |
| GSSGIIVRLSTNHFR | 106 | Q96J94 | |
| LHFGGRLAQSLRGTS | 696 | Q9BVN2 | |
| HRNELSGALTGLTRV | 441 | P26639 | |
| HSILTRGASVQLVFG | 161 | Q86TM6 | |
| VATQAGSLLHSLVLR | 336 | Q13285 | |
| HTRLVSLFNTTLTGL | 161 | Q9UQF0 | |
| GVIGLSLAQHTSRVL | 356 | Q96GJ1 | |
| GLVHSGLLIGISIAS | 511 | P07204 | |
| GRSGEALLLDTAHVL | 326 | Q6YHU6 | |
| LTEGRQLHITIAVTG | 271 | Q5TGY1 | |
| VDVHSLGARGISLLG | 21 | Q6DKJ4 | |
| GRTLHRSGSFINSLL | 261 | Q5UIP0 | |
| LLLLVLAAVTGHTAA | 16 | P09758 | |
| DLLVTVSASGLLGTH | 2406 | Q6ZNJ1 | |
| SRTLLGSHGQELLIE | 1911 | Q8NFP9 | |
| TLRLAGGQSVTHTGL | 36 | Q8NET5 | |
| SGRGASAHLVVLIAL | 131 | Q8NGU9 | |
| HTLRVGRTGGQALST | 1871 | P58107 | |
| VLGITSGIHDLGSLR | 196 | P48065 | |
| LRTGLVVLGAHVLST | 81 | Q6UWY2 | |
| EGGASLRLHTALFTK | 1456 | Q8TCU6 | |
| EVHAGLGELLRSLSN | 106 | P50454 | |
| VSHLKLSSSGLRGLS | 71 | Q92529 | |
| RQGSGEHTANLSLLL | 376 | Q92565 | |
| ILGTLESGHSRNLTC | 161 | Q9NYZ4 | |
| TGRHLSTGTFAILSL | 71 | Q8NG04 | |
| ELLLGHGAAVSRTNR | 1096 | Q9C0D5 | |
| RHINLTTLSVAGGFR | 231 | Q75T13 | |
| KGTLIRIFDTSSGHL | 206 | Q5MNZ6 | |
| GSVLLSGSHDETVRL | 281 | Q9BV38 | |
| GQLLALSTQRGSLHV | 331 | Q8NEZ3 | |
| GHSLGSLILFDILSN | 581 | Q9Y6Y8 | |
| LRTIIEGTRSSGSHL | 406 | Q14181 | |
| SHIRLALGVGRTLES | 276 | Q9GZT8 | |
| RSAGGLLRSQVIHSG | 36 | Q9NP71 | |
| GSALSVLEGQSLHLV | 386 | Q96PQ1 | |
| LTRIHILSFLSGLAE | 596 | Q8WXE9 | |
| GTLTAGGLARLLHSL | 51 | Q6ZMH5 | |
| GGSTSRLHSIEAILG | 26 | Q9Y2V3 | |
| TGGHLTATNLALSAL | 686 | P36956 | |
| LDLGFHLSRQTGALS | 236 | O75027 | |
| SISNSLHRELSAGLV | 1266 | Q09428 | |
| LHQALRGALDSLGTF | 11 | Q0VD83 | |
| VVLSRGTHGGFLTIN | 46 | Q92482 | |
| LSLHLGTATRGSDIS | 16 | Q9Y258 | |
| VSNFGRLASTLVHLG | 1221 | Q00610 | |
| LVALLGSLVDSSGHI | 276 | Q96KN2 | |
| TGLLSLSALGSQAHL | 161 | Q08117 | |
| TEGLRFLHTTVGSLL | 16 | Q9BQE4 | |
| IILNNFTTRLGHSIG | 246 | Q9H9Y2 | |
| LGSHVSVSEGALVLL | 26 | P01737 | |
| LGTGALRASLVHVGS | 66 | Q6PCB0 | |
| VDGILALGLGVHSRS | 136 | O95398 | |
| LTISTLGGSHYLLLD | 26 | Q6NUS8 | |
| LRLGSHAGSTRGSLL | 736 | Q70EL4 | |
| GKAATRLSILSLLGH | 81 | Q92574 | |
| LRVLSATSSGHLGFL | 671 | Q96KV7 | |
| ALGHLLVSTSSNRVV | 896 | Q96KV7 | |
| LENFGHLASLGLSIS | 76 | Q8N9K5 | |
| SGARIATSHGLSVLL | 211 | Q8TAG5 | |
| LVTTFRGHTGGVTAL | 191 | Q96P53 | |
| VTRSGLTVDQLHGVL | 1421 | Q99973 | |
| LAHSLLSGTGALLGL | 46 | A6NGC4 | |
| TSLTHLYLSIGLLSG | 101 | Q7RTY0 | |
| GGTVHSLGQTFLTIR | 151 | Q8NGC2 | |
| HTGILRRLDTSLGSA | 126 | Q9Y3D2 | |
| LHGTITQIRILGSTI | 436 | O76050 | |
| ARFTLGTVLGLATLH | 356 | Q9NRA0 | |
| RSLHILSTSKGLIAG | 166 | Q9Y5K1 | |
| LNHASLVLGARLSGA | 261 | O15270 | |
| SGLHGDVSLSNRLAL | 376 | Q9H6E5 | |
| RLVSSVHAVLATGSG | 41 | Q8TBR7 | |
| LTRAGLGSSAEHLVF | 126 | Q86VK4 | |
| SLRGSAIIELFHSSI | 1136 | Q9Y2I1 | |
| STLLHVNIRDSGVLS | 301 | O00624 | |
| LHISLGLGSTHLTRD | 396 | Q9UBT6 | |
| VLSSGTLRISGVALH | 481 | Q92626 | |
| ARVLEGTLAGHTLTA | 226 | A8MPS7 | |
| HRSVSVQDGILLATG | 316 | P48443 | |
| ATLVLSHGGHILAST | 441 | Q9BZZ2 | |
| GSGEGTHLSLYIRVL | 356 | Q9BUZ4 | |
| HLVSLGSGRLSTAIT | 41 | Q86UU1 | |
| HLAGLALFLTVVGSR | 76 | A0PJX8 | |
| TLATVGTGTFGRVHL | 51 | P51817 | |
| LTLQRATGISFAIHG | 6 | Q15393 | |
| HGSIISIFGLVVLSS | 81 | Q9NV29 | |
| LRHLGTFLGITIQSV | 316 | Q8TE23 | |
| LLALGALGSQAHLTV | 166 | Q04726 | |
| GHLGTATRELLFLLD | 346 | Q8N398 | |
| HHSLGRASGVVLTSL | 666 | P86452 | |
| GLGSFLLTHRTGLRS | 36 | Q86XT9 | |
| RGSHVVGLLTTLNFG | 81 | Q86XT9 | |
| TLHTRITAGYLLALG | 131 | Q7RTT9 | |
| GLVTLSGLSHLHSLV | 196 | Q9C0K7 | |
| LVVSLGGLTESTIRH | 986 | Q9BTW9 | |
| GLLASSITNLTVHIR | 856 | Q9C0G0 | |
| TLSHGAIAGIVLGSL | 771 | Q86VR7 | |
| HSGILNLASGVVDLL | 1471 | O15050 | |
| SLRNSSLVLGELHEG | 101 | P0DP72 | |
| LAHRAESLSRLSGGV | 141 | Q6NT89 | |
| TSSLLTRLGTLAQLH | 1246 | Q68DK2 | |
| SFLLLVISSDGHNGL | 16 | O95881 | |
| GTLARLGSVTHVTSF | 516 | P53814 | |
| SSLSLHGGLSSGLRL | 516 | Q96RL6 | |
| GIGLSSLNRHLRAFS | 111 | C9JN71 | |
| FGGILSLINEHRILS | 481 | O14773 | |
| ILSSVGLGTGLHTFL | 121 | Q96GC9 | |
| FVGLRVLGHTLRAST | 431 | Q14003 | |
| GLRVLGHTLRASTNE | 366 | Q03721 | |
| RLEGTGLALSLRHSS | 576 | Q9Y6N6 | |
| LVGSLSHDISRNVTL | 521 | Q8TDW0 | |
| GRGISHELISLEITS | 201 | P20592 | |
| GVSTSNLSDGILVIH | 936 | Q8N1T3 | |
| AFNGLTSLRLLHLEG | 146 | Q9NR99 |